Skip to main content
. 2015 Jul 29;6(29):27505–27518. doi: 10.18632/oncotarget.4752

Table 2. ERα and PR expression profiles in all patients.

Intensity Distribution
Marker Positive Weak Moderate Strong Focal Diffuse
N (%) N (%) N (%) N (%) N (%) N (%)
ERα (n = 913)
 Nucleus 157 (17) 118 (75) 27 (17) 12 (8) 138 (88) 19 (12)
 Cytoplasm 86 (9) 80 (93) 6 (7) 0 (0) 74 (86) 12 (14)
PR (n = 910)
 Nucleus 119 (13) 93 (78) 20 (17) 6 (5) 108 (91) 11 (9)
 Cytoplasm 116 (13) 87 (75) 21 (18) 8 (7) 80 (69) 36 (31)

ER, estrogen receptor; PR, progesterone receptor